Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Tokyo  >  Terumo Corp    4543   JP3546800008

SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

Terumo : Expands Production in Asia New Factory Established and Existing Facilities Expanded in Vietnam and the Philippines

share with twitter share with LinkedIn share with facebook
share via e-mail
0
05/10/2012 | 08:13am CEST
May 10, 2012

Terumo Corporation (TOKYO:4543) announced today that it will expand its production facilities in Asia to meet anticipated sales increases in the medium to long term, based on its corporate growth strategy. Terumo Corporation will establish a new factory in Vietnam, its second in the country, as well as expand the production scale of existing factories in Vietnam and the Philippines. The total amount invested will be 15 billion yen.

The new factory in Vietnam will produce blood management products such as blood bags to meet growing global demand, especially in emerging countries.
In cooperation with Ashitaka factory (Shizuoka prefecture) and the new Yamaguchi factory in Japan (operation to be started in 2015), the existing factory in Vietnam will expand the production scale of interventional systems products, sales of which have been growing at a double-digit pace. The company will also establish a new production building at the existing factory in the Philippines to cope with needed production increases of syringes and needles.
To improve its global competitiveness, Terumo Corporation is seeking to enhance the production capacity across all of its three business areas: Cardiac & Vascular, General Hospital, and Blood Management.

Terumo Corporation's global production system

Terumo Corporation is accelerating its growth globally, and plans to increase the percent of production done outside Japan in line with the growth in the share of net sales outside Japan, which already account for over half of the total. Accordingly, the company has positioned factories in Asia as its global production center and is already producing a broad range of products in China, the Philippines, and Vietnam.
On another front, certain highly advanced and precise production technologies are difficult to transfer outside of Japan. The company has designated factories in Japan as mother production factories that develop and refine core manufacturing technologies to underpin product improvement.
Terumo Corporation will continue to enhance its global production system in factories in Asia and Japan to meet growing global demand while increasing cost competitiveness.

Factories Overview 1. Vietnam: a new factory to be established

In April 2012, Terumo BCT was established through the integration of CaridianBCT and Terumo Transfusion, following Terumo Corporation's acquisition of CaridianBCT in April 2011. The company will establish a new factory in Vietnam to produce blood management products to meet growing global demand, especially in emerging countries. The factory will be its sixth production facilities of blood management products, following ones in Japan, U.S., UK

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on TERUMO CORP
07/27 TERUMO : Presolicitation Notice - Terumo Reagents
07/06 TERUMO : MicroVention Assigned Patent
06/28 TERUMO : Special Notice - Microvention Non-fluoroscopic endovascular aortic ball..
06/24 TERUMO : Notice regarding the appointment of Independent Committee Members for t..
06/24 TERUMO : Announces Voting Results for the Election of Directors
06/14 TERUMO : Japan's Terumo buying US brain catheter maker
06/14 TERUMO : Acquires Sequent Medical, U.S.-based Developer of New Aneurysm Emboliza..
06/10 TERUMO : FDA Lifts All Remaining Shipping Restrictions at Terumo Cardiovascular ..
06/10 TERUMO : FDA Lifts All Remaining Shipping Restrictions at Terumo Cardiovascular ..
06/06 TERUMO LAUNCHES HEARTSHEET® : A Global First Cellular and Tissue-based Product D..
More news
Sector news : Medical Equipment, Supplies & Distribution - NEC
09:58a Weak China sales drag down Smith & Nephew profits
07/27DJAlere Faces Criminal Probe Over Medicare, Medicaid Billing
07/26DJBAXTER : Results Boosted by Growth in Hospital Products Segment
07/25DJBAXTER : CFOs Turn to Consultants as Challenges Mount
07/22DJDEXCOM : Shares Rise After FDA Panel Vote
More sector news : Medical Equipment, Supplies & Distribution - NEC
Advertisement
Financials ( JPY)
Sales 2017 513 629 M
EBIT 2017 -
Net income 2017 54 166 M
Debt 2017 29 160 M
Yield 2017 0,92%
P/E ratio 2017 30,74
P/E ratio 2018 29,39
EV / Sales 2017 3,43x
EV / Sales 2018 3,18x
Capitalization 1 733 607 M
More Financials
Chart TERUMO CORP
Duration : Period :
Terumo Corp Technical Analysis Chart | 4543 | JP3546800008 | 4-Traders
Full-screen chart
Technical analysis trends TERUMO CORP
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 15
Average target price 4 387  JPY
Spread / Average Target -3,9%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Yutaro Shintaku President & Representative Director
Ryo Nishihata Chief Accounting & Financial Officer, IR Contact
Hiroaki Kasukawa CTO, Executive Officer, GM-Research & Development
Katsuya Takeuchi Executive Officer & Chief Information Officer
Takayoshi Mimura Director & Senior Managing Executive Officer
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
TERUMO CORP23.05%16 533
MEDTRONIC PLC13.73%122 011
BAXTER INTERNATIONAL I..26.66%26 685
ZIMMER BIOMET HOLDINGS..19.58%24 497
C R BARD INC18.06%16 398
DENTSPLY SIRONA INC2.86%14 661
More Results